RARA CRAFT DATABASE for FDA Medical Devices
PMAP200045S002

FDA DEVICE FACTS

RelayPro Thoracic Stent-Graft System

Bolton Medical, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEMarch 7, 2023PRODUCT CODEMIH

Indications for use

The Relay®Pro Thoracic Stent-Graft System is indicated for the endovascular repair of all lesions of the descending thoracic aorta in patients having appropriate anatomy, including: x Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories; x Non-aneurysmal aortic neck diameter in the range of: o 20 – 42 mm for fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers and dissections o 19 – 42 mm for traumatic aortic injuries; x Proximal landing zone (non-aneu rysmal proximal aortic neck lengths for fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers or non-dissected length of aorta proximal to the primary entr y tear for dissections and length of aorta proximal to the tear for traumatic aortic injuries) of: o 15 mm for the 22 – 28 mm device diameters (Bare Stent Configuration) o 20 mm for the 30 – 38 mm device diameters (Bare Stent Configuration) o 25 mm for the 40 – 46 mm device diameters (Bare Stent Configuration) o 25 mm for the 22 – 38 mm device diameters (Non-Bare Stent Configuration) o 30 mm for the 40 – 46 mm device diameters (Non-Bare Stent Configuration) x Non-aneurysmal distal aortic neck lengths for fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers of: o 25 mm for the 24 – 38 mm device diameters o 30 mm for the 40 – 46 mm device diameters x Non-aneurysmal distal landing zone of 20 mm for traumatic aortic injuries (22 mm – 46 mm device diameters) and dissections (24 mm – 46 mm device diameters) The Relay ®Pro Thoracic Stent-Graft System (NBS configuration) is indicated for the endovascular distal extension of the Thoraflex Hybrid device.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026